Published 15 June 2026
For years the powered exoskeleton has been a fixture of rehabilitation clinics and technology demonstrations rather than the home. In 2026 that picture is shifting, as lighter designs, smarter software and falling costs push wearable robotics closer to the kind of everyday mobility support offered today by walking aids and wheelchairs.
An exoskeleton is a wearable frame, usually fitted around the hips and legs, that uses motors to assist movement. Originally developed to help people with spinal injuries stand and walk during therapy, the technology is now being reimagined for daily life. Newer consumer focused devices are far lighter than the early medical models, with some assistive frames weighing only a few kilograms and offering ranges of around 20 kilometres on a charge.
The driving force is software. Artificial intelligence now allows these devices to read a person’s gait in real time and adjust motor assistance to match, smoothing each step rather than forcing a fixed motion. Real time gait analysis and adaptive motor control, once experimental, are increasingly described as standard features. The result is a device that supports the wearer’s own movement instead of replacing it, which is exactly what makes the idea appealing for people with reduced strength or stamina.
Market analysts expect rapid growth. The global personal mobility devices market, which includes powered exoskeletons alongside more familiar equipment, is forecast to expand strongly through the early 2030s, driven by ageing populations and rising demand for mobility assistance. Some projections for AI powered walking exoskeletons specifically point to double digit annual growth rates over the coming years.
It is important to be realistic about where the technology sits today. For most people, a well chosen mobility scooter or a quality set of mobility aids remains the practical, affordable choice, and exoskeletons are not yet a mainstream replacement. Cost, fitting and the need for some core stability mean these devices will suit a particular group of users rather than everyone. But the direction of travel is clear, and the gap between clinical equipment and consumer mobility products is narrowing.
Companies including Wandercraft, which has demonstrated self stabilising personal exoskeletons, and newer entrants offering lightweight powered frames, are racing to make the technology wearable outside the clinic. As prices come down and designs become less conspicuous, exoskeletons could eventually take their place alongside the daily living aids people already rely on.
For now, anyone interested should treat exoskeletons as an emerging option rather than a finished product, and seek a proper assessment before considering one. You can read more about the wider market trends from iHealthcareAnalyst and follow product developments from manufacturers such as DNSYS.
What is encouraging is the principle behind the technology, which is to keep people moving on their own two feet for longer. That goal sits at the heart of every mobility product we cover.
Related guides on Review Mobility
Published 15 June 2026